---
title: "AmoyDx obtains two medical device registration certificates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/224737146.md"
description: "AmoyDx recently obtained two medical device registration certificates issued by the National Medical Products Administration, namely HER-2 antibody reagent and estrogen receptor antibody reagent. This is the third approval for the company's immunohistochemical diagnostic products obtained in succession, aimed at guiding targeted therapy and endocrine therapy for breast cancer patients. This progress will enrich the company's product layout, enhance comprehensive competitiveness, and improve market expansion capabilities, positively impacting future development"
datetime: "2025-01-13T08:32:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/224737146.md)
  - [en](https://longbridge.com/en/news/224737146.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/224737146.md)
---

# AmoyDx obtains two medical device registration certificates

According to the Zhitong Finance APP, AmoyDx (300685.SZ) announced that it recently obtained two "Medical Device Registration Certificates of the People's Republic of China" issued by the National Medical Products Administration. The product names are: HER-2 antibody reagent (immunohistochemistry) and estrogen receptor antibody reagent (immunohistochemistry).

Recently, the company has continuously received approvals for three immunohistochemical diagnostic products: HER2 (human epidermal growth factor receptor 2), ER (estrogen receptor), and PR (progesterone receptor) antibody reagents, which are used to guide HER2-targeted therapy and endocrine therapy for breast cancer patients. The acquisition of the medical device registration certificates for the above products further enriches the company's product layout, enhances the company's overall competitiveness, improves its market expansion capabilities, and will have a positive impact on the company's future development

### Related Stocks

- [300685.CN](https://longbridge.com/en/quote/300685.CN.md)
- [301517.CN](https://longbridge.com/en/quote/301517.CN.md)

## Related News & Research

- [Bessent says Trump fixed Biden’s economy and it’s rising](https://longbridge.com/en/news/295985431.md)
- [Mark Sanders Highlights Growing Institutional Interest in Music Rights Through Asset-Based Investment Approach](https://longbridge.com/en/news/295679768.md)
- [thyssenkrupp nucera: Chlor-Alkali growth offsets green hydrogen softness; SOEC exit triggers EBIT hit and guidance cut](https://longbridge.com/en/news/295614348.md)
- [Can GLP-1s affect birth control, fertility?](https://longbridge.com/en/news/295570271.md)
- [07:47 ETKythera Labs Moves Up the Ranks on the 2026 Inc. 5000 List, the Most Prestigious Ranking of America's Fastest-Growing Private Companies](https://longbridge.com/en/news/295531532.md)